Vycor Medical (VYCO) Net Cash Flow Growth (3y) (2013 - 2026)
Vycor Medical (VYCO) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn | -87.88% |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn | -65.12% |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 129.29% |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn | -48.90% |
| 10 | Vycor Medical | 2.34 Mn | 2.16 Mn | 375,153.00 | 100.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.38% |
| Dec 31, 2025 | 72.08% |
| Sep 30, 2025 | -47.51% |
| Jun 30, 2025 | 47.78% |
| Mar 31, 2025 | -62.62% |
| Dec 31, 2024 | -83.72% |
| Sep 30, 2024 | 48.47% |
| Jun 30, 2024 | 2.70% |
| Mar 31, 2024 | -24.48% |
| Dec 31, 2023 | 25.92% |
| Sep 30, 2023 | 58.39% |
| Jun 30, 2023 | -22.01% |
| Mar 31, 2023 | 108.49% |
| Dec 31, 2022 | 29.08% |
| Sep 30, 2022 | -32.44% |
| Jun 30, 2022 | 2.35% |
| Mar 31, 2022 | -38.85% |
| Dec 31, 2021 | 97.69% |
| Sep 30, 2021 | -67.39% |
| Jun 30, 2021 | 63.15% |